Is a
Patent attributes
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
August 2, 2016
Patent Application Number
14001943
Date Filed
March 2, 2012
Patent Citations Received
Patent Primary Examiner
Patent abstract
This invention relates to the field of therapeutics. Disclosed are methods of conditionally expressing erythropoietin under the control of an ecdysone receptor-based gene expression modulation system in the presence of activating ligand and uses for therapeutic purposes in animals. The methods of the invention cause an in vivo increase in the expression of erythropoietin and an increase in the hematocrit or volume percentage of red blood cells in blood after administration of the ligand.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
